Own Wesfarmers shares? Here's where the health business is heading

The Wesfarmers share price is down 4% on no official news, but details have emerged about the company's new health division.

| More on:
A smiling woman applies face cream to her cheeks while looking in a mirror.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Wesfarmers has created a health division by purchasing Australian Pharmaceutical Industries (API) in March 2022 
  • The managing director of the new health segment plans to leverage API's loyalty program to boost sales 
  • She also wants to build 30 more Clear Skincare clinics 

The Wesfarmers Ltd (ASX: WES) share price is having a terrible day, down 4% in afternoon trading to $43.33.

There's been no market-sensitive news issued by the diversified conglomerate today.

However, according to an article in the Australian Financial Review (AFR), Wesfarmers has been busy with a bunch of changes to the businesses in its new health segment following the purchase of Australian Pharmaceutical Industries (API).

Wesfarmers bought API in a takeover deal finalised in March. The acquisition brought retail chains including Priceline Pharmacy, Pharmacist Advice, and Clear Skincare into the Wesfarmers portfolio.

Best known for owning Bunnings, Kmart, and Officeworks, the purchase represents Wesfarmers' first foray into the healthcare, beauty, and wellness space.

What will API do to the Wesfarmers share price?

Emily Amos is managing director of Wesfarmers' health segment. She was appointed in April shortly after the takeover was concluded.

Amos has done an interview with AFR outlining some of her first priorities.

According to the article, one of them is leveraging API's loyalty program to boost sales. It's the fourth largest of its kind in terms of market penetration in Australia.

Called Sister Club, the loyalty program has 7.5 million members. Amos wants to use it to increase sales, expand product ranges, and improve marketing.

She also wants to expand the network of Clear Skincare clinics, which offers anti-ageing, acne and laser treatments. There are currently 96 clinics across Australia and New Zealand. Amos wants to add 30 more.

Amos told AFR: "It's a good margin business, so it's really about operational execution and discipline."

The former API wholesale drug business recorded $3 billion in sales in fiscal year 2021 but with low margins.

Amos reckons she can improve things by making the distribution centre in Sydney's Marsden Park more efficient. She sees automation as the way to go and expects gains from the second half of this year, according to the article.

Bringing a new business into the fold involves many costs but also many potential rewards.

In Wesfarmers' FY22 full-year results, the health division recorded $1,240 million in revenue. But this trickled down to a $25 million loss in earnings before tax (EBT).

Of course, this is only over the three months that Wesfarmers owned its new health assets.

The picture changes if you take out $36 billion in acquisition-related and one-off expenses. In that scenario, earnings for the three-month period were $11 million.

Over this three-month timeframe, the Wesfarmers share price went down by 15%.

Motley Fool contributor Bronwyn Allen has positions in Wesfarmers Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

A businessman sits on a chair looking at a pile of chairs stacked up to the ceiling of a white empty room.
Share Market News

Here's how the ASX 200 market sectors stacked up last week

Consumer discretionary shares led the ASX 200 market sectors last week with a 0.36% gain.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Consumer Staples & Discretionary Shares

How much could a $10,000 investment in Woolworths shares become in one year?

Let's see what analysts are predicting for the supermarket giant's shares.

Read more »

A photo of a young couple who are purchasing fruits and vegetables at a market shop.
Consumer Staples & Discretionary Shares

Buying Coles shares? Here are key metrics you'll want to know

Grab a coffee and join me in this fun financial analysis exercise for Coles.

Read more »

a cute young girl with curly hair sips a glass of milk through a straw with a smile on her face.
Consumer Staples & Discretionary Shares

Guess which A2 Milk rival's shares just rocketed 21% on US news!

Up 65% in 2024, A2 Milk shares remain the better performer, but this rival is making up ground today.

Read more »

Happy smiling young woman drinking red wine while standing among the grapevines in a vineyard.
Consumer Staples & Discretionary Shares

What is boosting the Treasury Wine share price on Thursday?

This wine giant has some news that investors appear to be saying cheers to.

Read more »

a man inspects a capsicum while holding an eco-friendly green string bag in a supermarket produce aisle.
Consumer Staples & Discretionary Shares

Are Woolworths shares a bargain after falling 20%?

Is it time to put Woolworths stock in our share shopping basket?

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Consumer Staples & Discretionary Shares

Guess which beaten-up ASX 200 stock is being bought up by this multi-billion-dollar fundie

At least 3 fund managers have bought stakes in this ASX 200 consumer discretionary share this year.

Read more »

Young people shopping in mall and having fun.
Consumer Staples & Discretionary Shares

6 ASX retail shares to buy this month

Bell Potter has given its verdict on these retailers.

Read more »